Algernon Pharmaceuticals (XTER:BTI) Receivables Turnover : 0.00 (As of May. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Algernon Pharmaceuticals Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Algernon Pharmaceuticals's Revenue for the three months ended in May. 2024 was €0.00 Mil. Algernon Pharmaceuticals's average Accounts Receivable for the three months ended in May. 2024 was €0.00 Mil.

Algernon Pharmaceuticals Receivables Turnover Historical Data

The historical data trend for Algernon Pharmaceuticals's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Algernon Pharmaceuticals Receivables Turnover Chart

Algernon Pharmaceuticals Annual Data

Trend

Aug15

Aug16

Aug17

Aug18

Aug19

Aug20

Aug21

Aug22

Aug23

Receivables Turnover

Get a 7-Day Free Trial

Algernon Pharmaceuticals Quarterly Data
	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24
Receivables Turnover	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Algernon Pharmaceuticals's Receivables Turnover

For the Biotechnology subindustry, Algernon Pharmaceuticals's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Algernon Pharmaceuticals's Receivables Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Algernon Pharmaceuticals's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Algernon Pharmaceuticals's Receivables Turnover falls into.

Algernon Pharmaceuticals Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Algernon Pharmaceuticals's Receivables Turnover for the fiscal year that ended in Aug. 2023 is calculated as

	Receivables Turnover (A: Aug. 2023 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: Aug. 2023 )	/ (	(Accounts Receivable (A: Aug. 2022 )	+	Accounts Receivable (A: Aug. 2023 ))	/	count )
=	0	/ (	(0	+	0)	/	1 )
=	0	/	0
=	N/A

Algernon Pharmaceuticals's Receivables Turnover for the quarter that ended in May. 2024 is calculated as

	Receivables Turnover (Q: May. 2024 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: May. 2024 )	/ (	(Accounts Receivable (Q: Feb. 2024 )	+	Accounts Receivable (Q: May. 2024 ))	/	count )
=	0	/ (	(0	+	0)	/	1 )
=	0	/	0
=	N/A

Algernon Pharmaceuticals (XTER:BTI) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Algernon Pharmaceuticals Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Algernon Pharmaceuticals's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Algernon Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Algernon Pharmaceuticals Inc (XTER:BTI) » Definitions » Receivables Turnover

Comparable Companies

Traded in Other Exchanges

AGNPF:USA AGW0:Germany AGN:Canada

Address

601 West Broadway, Suite 400, Vancouver, BC, CAN, V5Z 4C2

Website

https://www.algernonpharmaceuticals.com

Algernon Pharmaceuticals Inc is a clinical-stage drug development company focused on the disease areas of stroke, idiopathic pulmonary fibrosis and chronic cough. The company's business model is capital efficient and strives to deliver maximum shareholder value. Algernon's approach to drug discovery is based on the concept of drug repurposing. It operates in two reportable segments: the development of repurposed therapeutic drugs in Canada, and the facilitation of the Company's drug candidates into off-label phase II clinical trials (humans) in Australia.